چکیده (انگلیسی):

Background:A territory-wide diabetes management program (Risk Assessment Management Program–RAMP)
was recently established, providing comprehensive management for all diabetics, helping to delineate current level
of control and complications prevalence among primary care diabetic patients in Hong Kong.
Method:This cross-sectional study captured anonymous clinical data from RAMP patients. Data obtained include
sociodemographic details, type of diabetes, illness duration, family history, drug usage, coexisting illnesses, diabetic
complications and other clinical parameters.
Results:Data from 15,856 type 2 diabetic patients were analyzed. 57.1% were above 60 years old, with mean
disease duration of 7.3 years. Hypertension was the commonest coexisting chronic illness (57.6%). 30.2% and 61.8%
have their systolic and diastolic pressure controlled to below 130 mmHg and 80 mmHg respectively. Over half
(51.5%) had an HbA1c level of less than 7.0%. 88.4% did not achieve target lipid level. 15% were on diet control
alone. Only 22.2% were on statins. In patients with microalbuminuria and macroalbuminuria, 40.7% and 54.5% were
on angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) respectively. 12.9%, 38.8%
and 2.4% had diabetic retinopathy, nephropathy and neuropathy respectively. Overall, 37.9%, 7.3% and 0.4% had
single, two and three concurrent microvascular complications respectively.
Conclusion:The level of diabetic control is comparable with other developed countries. We demonstrated a high
prevalence of microvascular complications among Chinese primary care patients despite achieving adequate HbA1c
levels, highlighting the importance of managing all aspects of diabetes including weight, lipid and blood pressure.
Efforts to improve holistic management must be tailored according to the needs of our population, with the
challenges that the majority have low educational background and in the older age group.